Literature DB >> 34882130

Incidence and risk factors of long COVID in the UK: a single-centre observational study.

Arvind Nune1, Victor Durkowski2, Andrew Titman3, Latika Gupta4, Marin Hadzhiivanov2, Ashar Ahmed2, Cristina Musat2, Hem R Sapkota5.   

Abstract

BACKGROUND: Studies to evaluate long COVID symptoms and their risk factors are limited. We evaluated the presence of long COVID and its risk factors in patients discharged from a hospital with COVID-19 illness.
METHODS: This observational study included 271 COVID-19 patients admitted between February and July 2020 in a hospital in the UK. The primary outcome measure was to assess the duration and severity of long COVID and its predictors at 3, 6 and 9 months. Logistic regression was performed to assess the potential risk factors for long COVID.
RESULTS: Out of 89 patients interviewed, 55 (62%) had long COVID for 3 months, 46 (52%) for 6 months and 37 of the 75 patients admitted to the hospital with acute COVID-19 had long COVID for 9 months (49%). The most common long COVID symptoms were fatigue and breathlessness.
CONCLUSION: Nearly two-thirds of patients at 3 months and a half at 9 months had long COVID. COVID-19 pneumonia was the strongest predictor of long COVID in Caucasians at 3 months.

Entities:  

Keywords:  COVID-19; coronavirus; long COVID; pandemics; post COVID-19 syndrome

Mesh:

Year:  2021        PMID: 34882130     DOI: 10.4997/JRCPE.2021.405

Source DB:  PubMed          Journal:  J R Coll Physicians Edinb        ISSN: 1478-2715


  2 in total

1.  Post-COVID-19 Condition and İts Recognition in Low- and Middle-income Countries: Working Notes from the United Kingdom Experience.

Authors:  Arvind Nune; Karthikeyan P Iyengar; Bhupen Barman; Ciro Manzo
Journal:  Balkan Med J       Date:  2022-07-22       Impact factor: 3.570

Review 2.  The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications.

Authors:  Douglas B Kell; Etheresia Pretorius
Journal:  Biochem J       Date:  2022-08-31       Impact factor: 3.766

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.